News and Announcements
4Dx Featured on Start Up Smart and SBS Radio
- Published April 04, 2016 1:13PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Andreas Fouras, Founder and Executive Chairman of 4Dx talks to Start Up Smart and SBS Radio about his vision of making a life-changing contribution to global healthcare, and his confidence in this opportunity to build a multi-billion dollar business.
To read “All in”: What happened when a university professor quit his job and sold his house to pursue a “life-changing” idea, please click on the button below.
To listen to “4Dx technology is spreading in US” please click on the button below.
ABOUT 4DX
4Dx Pty Ltd is a medical technology start-up based in Melbourne, Australia, established to commercialise four-dimensional lung imaging technology: 4DxV.
Conceived by 4Dx founder Andreas Fouras and developed by his research group, the Laboratory for Dynamic Imaging at Monash University, this four-dimensional X-ray imaging technology maps the motion and airflow within the breathing lung. This provides information on regional lung function not available in today’s medical clinics.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
